215 related articles for article (PubMed ID: 10386036)
1. [The combination therapy of clarithromycin and sparfloxacin for pulmonary Mycobacterium gordonae infection].
Tomiyama Y; Maesaki S; Yong B; Higashiyama Y; Miyazaki Y; Tomono K; Tashiro T; Kohno S
Kekkaku; 1999 May; 74(5):457-61. PubMed ID: 10386036
[TBL] [Abstract][Full Text] [Related]
2. [A case of pulmonary Mycobacterium gordonae infection diagnosed by gastric juice culture and successfully treated with multidrug chemotherapy].
Nakazawa A; Hagiwara E; Ikeda S; Oda T; Komatsu S; Ogura T
Kekkaku; 2012 Nov; 87(11):727-31. PubMed ID: 23367832
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of combined clarithromycin and sparfloxacin therapy in a patient with discitis: due to Mycobacterium xenopi.
Roche B; Rozenberg S; Cambau E; Desplaces N; Dion E; Dubourg G; Koeger AC; Robin H; Vergeron H; Bourgeois P
Rev Rhum Engl Ed; 1997 Jan; 64(1):64-5. PubMed ID: 9051864
[No Abstract] [Full Text] [Related]
4. Successful treatment of pulmonary Mycobacterium xenopi infection in a natural killer cell-deficient patient with clarithromycin, rifabutin, and sparfloxacin.
Schmitt H; Schnitzler N; Riehl J; Adam G; Sieberth HG; Haase G
Clin Infect Dis; 1999 Jul; 29(1):120-4. PubMed ID: 10433574
[TBL] [Abstract][Full Text] [Related]
5. [Pulmonary Mycobacterium gordonae infection treated with clarithromycin].
Koizumi T; Yamazaki Y; Kubo K; Yaguchi Y; Yanagisawa H; Yamauchi K
Kekkaku; 2000 Dec; 75(12):711-5. PubMed ID: 11201139
[TBL] [Abstract][Full Text] [Related]
6. Disseminated Mycobacterium gordonae infection in an immunocompetent host.
Asija A; Prasad A; Eskridge E
Am J Ther; 2011 May; 18(3):e75-7. PubMed ID: 21566466
[TBL] [Abstract][Full Text] [Related]
7. Nine-year progression of untreated pulmonary Mycobacterium szulgai infection.
Randhawa K; Smethurst P; Soo Hoo GW
South Med J; 2010 Aug; 103(8):828-30. PubMed ID: 20622732
[TBL] [Abstract][Full Text] [Related]
8. [Pulmonary infection caused by Mycobacterium gordonae in immunocompetent patient].
Fujita Y; Matsumoto H; Fujikane T; Nakao S; Sasaki N; Takahashi M; Sato K; Takeda A; Yamazaki Y; Tobise K
Kekkaku; 2000 Apr; 75(4):369-74. PubMed ID: 10808280
[TBL] [Abstract][Full Text] [Related]
9. [A case of Mycobacterium abscessus pulmonary infection; effectiveness of clarithromycin, amikacin and imipenem/cilastatin].
Shikama Y; Kamio Y; Kuriu K; Shibuya Y; Kimura S; Nakajima H
Nihon Kokyuki Gakkai Zasshi; 2006 Nov; 44(11):800-6. PubMed ID: 17144576
[TBL] [Abstract][Full Text] [Related]
10. [Mycobacterium malmoense infection in an immunocompetent patient].
Guiot J; Ramaut M; Massart B; Louis R
Rev Med Liege; 2009; 64(7-8):390-3. PubMed ID: 19777918
[TBL] [Abstract][Full Text] [Related]
11. [Pulmonary mycobacteriosis caused by Mycobacterium peregrinum in a young, healthy man].
Sawahata M; Hagiwara E; Ogura T; Komatsu S; Sekine A; Tsuchiya N; Takahashi H
Nihon Kokyuki Gakkai Zasshi; 2010 Nov; 48(11):866-70. PubMed ID: 21141068
[TBL] [Abstract][Full Text] [Related]
12. [Two cases of pulmonary infection by Mycobacterium abscessus in which drug susceptibility testing results conflicted with clinical courses].
Nishizawa Y; Fujimura M; Tagami A; Abo M; Honjyo C; Yasui M; Nakao S
Nihon Kokyuki Gakkai Zasshi; 2005 Apr; 43(4):241-6. PubMed ID: 15966372
[TBL] [Abstract][Full Text] [Related]
13. [A case of bronchial ulcer due to infection by Mycobacterium abscessus].
Kasai S; Tokuda H; Yoshikawa M; Nishiyama H
Nihon Kokyuki Gakkai Zasshi; 2004 Oct; 42(10):919-23. PubMed ID: 15566008
[TBL] [Abstract][Full Text] [Related]
14. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
[TBL] [Abstract][Full Text] [Related]
15. [A case of pulmonary Mycobacterium gordonae infection with pleural effusion].
Saeki S; Matsuse H; Shimoda T; Soejima Y; Ohno H; Kohno S
Nihon Kokyuki Gakkai Zasshi; 2004 Jan; 42(1):103-7. PubMed ID: 14768374
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary Mycobacterium szulgai infection and treatment in a patient receiving anti-tumor necrosis factor therapy.
van Ingen J; Boeree M; Janssen M; Ullmann E; de Lange W; de Haas P; Dekhuijzen R; van Soolingen D
Nat Clin Pract Rheumatol; 2007 Jul; 3(7):414-9. PubMed ID: 17599076
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.
Koh WJ; Jeon K; Lee NY; Kim BJ; Kook YH; Lee SH; Park YK; Kim CK; Shin SJ; Huitt GA; Daley CL; Kwon OJ
Am J Respir Crit Care Med; 2011 Feb; 183(3):405-10. PubMed ID: 20833823
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and treatment of atypical mycobacterial infections of the respiratory tract].
Andréjak C; Lescure FX; Schmit JL; Jounieaux V
Rev Mal Respir; 2011 Dec; 28(10):1293-309. PubMed ID: 22152937
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection.
Murray MP; Laurenson IF; Hill AT
Clin Infect Dis; 2008 Jul; 47(2):222-4. PubMed ID: 18532890
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary Mycobacterium kyorinense disease showed clinical improvement following combined therapy with clarithromycin and levofloxacin.
Kobashi Y; Mouri K; Obase Y; Kato S; Oka M
Intern Med; 2012; 51(14):1923-6. PubMed ID: 22821114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
